Restoret

N/A

Report date: 2024/11/28 14:33:19

Base Information

Drug NameRestoret
Drug Alias NameEYE103EYE-103MK-3000ANT-39
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody
Mechanisms of ActionWnt signalling pathway modulatorsFrizzled-4 modulatorsLow-density lipoprotein receptor-related protein 5 modulators
TargetsFrizzled-4Low-density lipoprotein receptor-related protein 5
Therapy Area/IndicationsDiabetic macular oedemaRetinal Vein OcclusionMacular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaUnited StatesSlovakia +[22] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesEyebiotech Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEyebiotech Ltd
Inactive CompaniesN/A
Active IndicationsDiabetic macular oedemaRetinal Vein OcclusionMacular Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A